Published in Chem Biol Interact on October 01, 1979
Neurotoxicity of a prion protein fragment. Nature (1993) 3.38
Defective inflammatory response in interleukin 6-deficient mice. J Exp Med (1994) 2.92
CtBP/BARS induces fission of Golgi membranes by acylating lysophosphatidic acid. Nature (1999) 2.81
Multimer formation and ligand recognition by the long pentraxin PTX3. Similarities and differences with the short pentraxins C-reactive protein and serum amyloid P component. J Biol Chem (1997) 1.97
In vivo anti-inflammatory effect of statins is mediated by nonsterol mevalonate products. Arterioscler Thromb Vasc Biol (2001) 1.88
Regulation of the macrophage content of neoplasms by chemoattractants. Science (1983) 1.83
Effectiveness of anthracycline against experimental prion disease in Syrian hamsters. Science (1997) 1.70
Evaluation of quinacrine treatment for prion diseases. J Virol (2003) 1.59
A metabolic explantation for differences between species of the anticonvulsant activity of diazepam. Br J Pharmacol (1968) 1.39
Molecular cloning and functional characterization of brefeldin A-ADP-ribosylated substrate. A novel protein involved in the maintenance of the Golgi structure. J Biol Chem (1999) 1.39
Inhibition of monocyte chemotactic protein-1 synthesis by statins. Lab Invest (2000) 1.38
Cloning of mouse ptx3, a new member of the pentraxin gene family expressed at extrahepatic sites. Blood (1996) 1.37
A 7-kDa prion protein (PrP) fragment, an integral component of the PrP region required for infectivity, is the major amyloid protein in Gerstmann-Sträussler-Scheinker disease A117V. J Biol Chem (2000) 1.34
Cytokine induction of haem oxygenase mRNA in mouse liver. Interleukin 1 transcriptionally activates the haem oxygenase gene. Biochem J (1993) 1.33
Apoptosis mediated neurotoxicity induced by chronic application of beta amyloid fragment 25-35. Neuroreport (1993) 1.28
Collagen proline hydroxylase in wound healing, granuloma formation, scurvy, and growth. Science (1967) 1.26
Alteration of the porphyrin nucleus of cytochrome P-450 caused in the liver by treatment with allyl-containing drugs. Is the modified porphyrin N-substituted? Biochem J (1979) 1.24
Molecular characteristics of a protease-resistant, amyloidogenic and neurotoxic peptide homologous to residues 106-126 of the prion protein. Biochem Biophys Res Commun (1993) 1.23
Anti-amyloidogenic activity of tetracyclines: studies in vitro. FEBS Lett (2001) 1.21
p21WAF1-derived peptides linked to an internalization peptide inhibit human cancer cell growth. Cancer Res (1997) 1.21
Carrageenan-induced acute inflammation in the mouse air pouch synovial model. Role of tumour necrosis factor. Mediators Inflamm (1997) 1.21
Alteration of elastin, collagen and their cross-links in abdominal aortic aneurysms. Eur J Vasc Endovasc Surg (2002) 1.16
Diazepam elimination in premature and full term infants, and children. J Perinat Med (1973) 1.15
Role of bile acids and metabolic activity of colonic bacteria in increased risk of colon cancer after cholecystectomy. Dig Dis Sci (1993) 1.10
Tetracycline affects abnormal properties of synthetic PrP peptides and PrP(Sc) in vitro. J Mol Biol (2000) 1.09
Purification, cDNA cloning, and tissue distribution of bovine liver aldehyde oxidase. J Biol Chem (1995) 1.08
Conformational polymorphism of the amyloidogenic and neurotoxic peptide homologous to residues 106-126 of the prion protein. J Biol Chem (1994) 1.07
Quantitative GLC determination of cyclophosphamide and isophosphamide in biological specimens. J Pharm Sci (1974) 1.05
Enhanced xanthine oxidase activity in mice treated with interferon and interferon inducers. Biochem Biophys Res Commun (1984) 1.05
IFN-beta-induced reduction of superoxide anion generation by macrophages. Immunology (1982) 1.04
Mechanisms of endotoxin-induced haem oxygenase mRNA accumulation in mouse liver: synergism by glutathione depletion and protection by N-acetylcysteine. Biochem J (1994) 1.04
Microglial cells respond to amyloidogenic PrP peptide by the production of inflammatory cytokines. Neuroreport (1999) 1.04
Role of reactive oxygen intermediates in the interferon-mediated depression of hepatic drug metabolism and protective effect of N-acetylcysteine in mice. Cancer Res (1985) 1.02
Tumor-derived chemotactic factor(s) from human ovarian carcinoma: evidence for a role in the regulation of macrophage content of neoplastic tissues. Int J Cancer (1985) 1.01
A soluble form of prion protein in human cerebrospinal fluid: implications for prion-related encephalopathies. Biochem Biophys Res Commun (1992) 1.00
In vitro inhibitory effect on porphyrinogen carboxylyase of liver extracts from TCDD treated mice. Toxicol Lett (1984) 1.00
Chemotactic activity for mononuclear phagocytes of culture supernatants from murine and human tumor cells: evidence for a role in the regulation of the macrophage content of neoplastic tissues. Int J Cancer (1983) 0.99
Studies on the disposition of cyclophosphamide (NSC-26271) in tumor-bearing mice by means of gas chromatography-chemical ionization-mass fragmentography. Cancer Treat Rep (1976) 0.98
Molybdenum(VI) salts convert the xanthine oxidoreductase apoprotein into the active enzyme in mouse L929 fibroblastic cells. Biochem J (1994) 0.98
Induction of apoptosis in human leukemic cells by the ether lipid 1-octadecyl-2-methyl-rac-glycero-3-phosphocholine. A possible basis for its selective action. Int J Cancer (1993) 0.98
Phosphatidic acid and lysophosphatidic acid induce haptotactic migration of human monocytes. J Biol Chem (1995) 0.97
Determination of ambroxol in biological material by gas chromatography with electron-capture detection. J Chromatogr (1990) 0.97
A neurotoxic prion protein fragment induces rat astroglial proliferation and hypertrophy. Eur J Neurosci (1994) 0.97
Effects of phlebotomy on urinary porphyrin pattern and liver histology in patients with porphyria cutanea tarda. Am J Med Sci (1983) 0.97
Effect of phenobarbital on the in vitro metabolism of diazepam in several animal species. Biochem Pharmacol (1970) 0.96
Prion protein fragment 106-126 induces apoptotic cell death and impairment of L-type voltage-sensitive calcium channel activity in the GH3 cell line. J Neurosci Res (1998) 0.96
Membrane fluidity affects tumor-cell motility, invasion and lung-colonizing potential. Int J Cancer (1989) 0.94
Biochemical assay of collagen and elastin in the normal and varicose vein wall. J Surg Res (1996) 0.94
Aging and food restriction: effect on lipids of cerebral cortex. Neurobiol Aging (1991) 0.94
Inhibition of cancer cell growth and c-Myc transcriptional activity by a c-Myc helix 1-type peptide fused to an internalization sequence. Cancer Res (1998) 0.93
Interferon decreases production of hydrogen peroxide by macrophages: correlation with reduction of suppressive capacity and of anti-microbial activity. Immunology (1983) 0.93
Mitochondrial dysfunction and death in motor neurons exposed to the glutathione-depleting agent ethacrynic acid. J Neurol Sci (2003) 0.93
Kupffer cell depletion partially prevents hepatic heme oxygenase 1 messenger RNA accumulation in systemic inflammation in mice: role of interleukin 1beta. Hepatology (1998) 0.92
A gas chromatographic method for the determination of amantadine in human plasma. J Chromatogr (1972) 0.91
The structure of vacidin A, an aromatic heptaene macrolide antibiotic. I. Complete assignment of the 1H NMR spectrum and geometry of the polyene chromophore. J Antibiot (Tokyo) (1989) 0.91
The stimulation of inducible nitric-oxide synthase by the prion protein fragment 106--126 in human microglia is tumor necrosis factor-alpha-dependent and involves p38 mitogen-activated protein kinase. J Biol Chem (2001) 0.90
Further studies on species difference in diazepam metabolism. Eur J Pharmacol (1970) 0.90
Decreased half life of cyclophosphamide in patients under continual treatment. Eur J Cancer (1979) 0.90
Intracellular calcium rise through L-type calcium channels, as molecular mechanism for prion protein fragment 106-126-induced astroglial proliferation. Biochem Biophys Res Commun (1996) 0.89
Application of gas chromatography-chemical ionization mass fragmentography in the evaluation of bases and nucleoside analogues used in cancer chemotherapy. J Chromatogr (1974) 0.89
Characterization of type II intracellular IL-1 receptor antagonist (IL-1ra3): a depot IL-1ra. Eur J Immunol (1999) 0.88
Stereostructure and NMR characterization of the antibiotic candidin. J Antibiot (Tokyo) (1993) 0.88
The metabolism of diazepam by liver microsomal enzymes of rats and mice. Eur J Pharmacol (1969) 0.87
Amino terminal region of acute phase, but not constitutive, serum amyloid A (apoSAA) specifically binds and transports cholesterol into aortic smooth muscle and HepG2 cells. J Lipid Res (1996) 0.87
Cloning of the cDNAs coding for two novel molybdo-flavoproteins showing high similarity with aldehyde oxidase and xanthine oxidoreductase. J Biol Chem (2000) 0.87
In vivo exposure to NO2 reduces TNF and IL-6 production by endotoxin-stimulated alveolar macrophages. Am J Physiol (1996) 0.87
Serum protease inhibitor concentrations and total antitrypsin activity in diabetic and non-diabetic children during adolescence. Acta Diabetol (2006) 0.87
Apoptosis-mediated neurotoxicity induced by beta-amyloid and PrP fragments. Mol Chem Neuropathol (1997) 0.86
Biochemical markers of upper esophageal sphincter compliance in patients with Zenker's diverticulum. J Surg Res (1997) 0.86
Purification of the aldehyde oxidase homolog 1 (AOH1) protein and cloning of the AOH1 and aldehyde oxidase homolog 2 (AOH2) genes. Identification of a novel molybdo-flavoprotein gene cluster on mouse chromosome 1. J Biol Chem (2001) 0.86
Activation effects of a prion protein fragment [PrP-(106-126)] on human leucocytes. Biochem J (1996) 0.86
Microsomal styrene mono-oxygenase and styrene epoxide hydrase activities in rats. Xenobiotica (1976) 0.86
Studies on peptide fragments of prion proteins. Adv Protein Chem (2001) 0.85
Amyloid in Alzheimer's disease and prion-related encephalopathies: studies with synthetic peptides. Prog Neurobiol (1996) 0.85
Anticonvulsant activity and brain levels of diazepam and its metabolites in mice. Eur J Pharmacol (1972) 0.85
The structure of vacidin A, an aromatic heptaene macrolide antibiotic. II. Stereochemistry of the antibiotic. J Antibiot (Tokyo) (1989) 0.85
Apoptotic cell death and impairment of L-type voltage-sensitive calcium channel activity in rat cerebellar granule cells treated with the prion protein fragment 106-126. Neurobiol Dis (2000) 0.85
Beta-lactam antibiotics active against methicillin-resistant Staphylococcus aureus. J Infect Dis (1991) 0.85
Hydroxychloroquine versus phlebotomy in the treatment of porphyria cutanea tarda. Br J Dermatol (1983) 0.85
Species difference in diazepam metabolism and anticonvulsant effect. Eur J Pharmacol (1968) 0.85
Gas chromatographic degradation of several drugs and their metabolites. Anal Chem (1973) 0.85
N-acetyl-beta-D-glucosaminidase (NAG) levels in amniotic fluid or urine in prenatal and postnatal life. Early Hum Dev (1986) 0.84
Spectroscopic and binding studies on the interaction of inorganic anions with lactoperoxidase. J Inorg Biochem (1997) 0.84
Plasma and red blood cell phospholipids in chronic liver diseases. Clin Chim Acta (1975) 0.84
The effect of injections of fluorocitrate into the brains of rats. Biochem Pharmacol (1968) 0.84
The effect of culture medium composition on ether lipid cytotoxic activity. Lipids (1993) 0.84
Localization and age-dependent expression of the inward rectifier K+ channel subunit Kir 5.1 in a mammalian reproductive system. FEBS Lett (1999) 0.84
Measurement of intracellular calcium levels by the fluorescent Ca(2+) indicator Calcium-Green. Brain Res Brain Res Protoc (2000) 0.84
beta PP and Tau interaction. A possible link between amyloid and neurofibrillary tangles in Alzheimer's disease. Am J Pathol (1996) 0.84
Extracellular glutamate levels in the hypothalamus and hippocampus of rats after acute or chronic oral intake of monosodium glutamate. Neurosci Lett (1995) 0.84
ATPase activity defects in alloxan-induced diabetic sciatic nerve recovered by ganglioside treatment. Diabetes (1988) 0.83
Stereostructure of Rimocidin. J Antibiot (Tokyo) (1995) 0.83
Role of surfactant in chronic obstructive pulmonary disease: therapeutic implications. Respiration (1992) 0.83
A biodistribution study of PEGylated PCL-based nanoparticles in C57BL/6 mice bearing B16/F10 melanoma. Nanotechnology (2014) 0.83
Loss of haem and haemoproteins during the generation of superoxide anion and hydrogen peroxide: a pathway not involving production of carbon monoxide. Int J Biochem (1981) 0.83